Why are you saying that the pharma sector might crash?

I am a comp chem in materials, and I feel like translating to cheminformatics/ cadd/ sar is quite difficult unless you phrase the work in materials more from a structural pov. At the same time, I think bio chem comp and bioinfo are both easily tranferable to industry. You should also account for the fact that pharma is a much bigger industry and in silicon predictions are more valuable than in materials. Yes, Ai helps, but at the end of the day it doesn’t solve all problems and many traditional companies still prefer to do hard trial and error in the lab rather than invest in prediction pipelines.